We are live on ! Find out more
TWA

TCI Wealth Advisors Portfolio holdings

AUM $2.31B
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+26.52%
3 Year Est. Return
+65.05%
5 Year Est. Return
+75.05%
10 Year Est. Return
+319.89%
AUM
$771M
AUM Growth
+$48.1M
Cap. Flow
+$19.8M
Cap. Flow %
2.57%
Top 10 Hldgs %
61.77%
Holding
2,702
New
213
Increased
620
Reduced
612
Closed
187

Sector Composition

Rank Sector Weight
1 Technology 5.25%
2 Healthcare 3.55%
3 Industrials 2.86%
4 Financials 2.68%
5 Consumer Discretionary 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OM icon
1851
Outset Medical
OM
$92.5M
$3K ﹤0.01%
+11
New +$4.04K
CW icon
1852
Curtiss-Wright
CW
$27.6B
$3K ﹤0.01%
17
-1
-6% -$169
CBAY
1853
DELISTED
Cymabay Therapeutics
CBAY
$2.97K ﹤0.01%
+341
New +$2.73K
AMAL icon
1854
Amalgamated Financial
AMAL
$1.48B
$2.97K ﹤0.01%
168
REYN icon
1855
Reynolds Consumer Products
REYN
$5.32B
$2.97K ﹤0.01%
108
-1
-0.9% -$28
PTGX icon
1856
Protagonist Therapeutics
PTGX
$8.51B
$2.97K ﹤0.01%
+129
New +$2.17K
WHWK
1857
Whitehawk Therapeutics
WHWK
$196M
$2.96K ﹤0.01%
+409
New +$4.37K
PTEN icon
1858
Patterson-UTI
PTEN
$3.9B
$2.96K ﹤0.01%
253
-62
-20% -$905
AMCR icon
1859
Amcor
AMCR
$21.3B
$2.96K ﹤0.01%
52
-2
-4% -$115
CBOE icon
1860
Cboe Global Markets
CBOE
$31.1B
$2.95K ﹤0.01%
22
CHWY icon
1861
Chewy
CHWY
$9.4B
$2.95K ﹤0.01%
79
U icon
1862
Unity
U
$14.6B
$2.95K ﹤0.01%
91
-90
-50% -$2.9K
SBRA icon
1863
Sabra Healthcare REIT
SBRA
$5.2B
$2.94K ﹤0.01%
256
-539
-68% -$6.67K
DMTK
1864
DELISTED
DermTech, Inc. Common Stock
DMTK
$2.94K ﹤0.01%
+800
New +$3.37K
SSNC icon
1865
SS&C Technologies
SSNC
$18.6B
$2.94K ﹤0.01%
52
+2
+4% +$115
DORM icon
1866
Dorman Products
DORM
$3.82B
$2.93K ﹤0.01%
34
RNAM
1867
DELISTED
Avidity Biosciences
RNAM
$2.89K ﹤0.01%
+188
New +$4.14K
DOX icon
1868
Amdocs
DOX
$5.88B
$2.88K ﹤0.01%
30
SEIC icon
1869
SEI Investments
SEIC
$12.5B
$2.88K ﹤0.01%
50
ALLO icon
1870
Allogene Therapeutics
ALLO
$635M
$2.88K ﹤0.01%
582
-103
-15% -$661
VMI icon
1871
Valmont Industries
VMI
$9.43B
$2.87K ﹤0.01%
9
LGND icon
1872
Ligand Pharmaceuticals
LGND
$5.85B
$2.87K ﹤0.01%
39
BTAI icon
1873
BioXcel Therapeutics
BTAI
$26.2M
$2.85K ﹤0.01%
+10
New +$4.27K
FSR
1874
DELISTED
Fisker Inc.
FSR
$2.85K ﹤0.01%
464
PRME icon
1875
Prime Medicine
PRME
$508M
$2.84K ﹤0.01%
+231
New +$3.76K

Similar funds

TCI Wealth Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, TCI Wealth Advisors held 2,702 positions worth $771M, up 6.7% from $722M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

TCI Wealth Advisors's Q1 2023 filing shows 213 new, 620 increased, 612 reduced and 187 closed positions. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 2,948 shares worth $214K. The largest sale was iShares Core US Aggregate Bond ETF, an estimated $5.62M.

By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 4.6% a quarter earlier, followed by Healthcare and Industrials.

  • TCI Wealth Advisors's largest Q1 2023 buy was iShares MSCI USA Min Vol Factor ETF: 2,948 shares worth $214K.
  • TCI Wealth Advisors added most to Dimensional US Small Cap ETF in Q1 2023, an estimated $4.13M increase.
  • TCI Wealth Advisors's biggest Q1 2023 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $5.62M.
  • TCI Wealth Advisors fully exited Meridian Bioscience Inc in Q1 2023, selling an estimated $386K.
  • TCI Wealth Advisors's ten largest holdings make up 62% of its $771M portfolio in Q1 2023.
  • TCI Wealth Advisors opened 213 new positions and closed 187 in Q1 2023.
  • TCI Wealth Advisors's portfolio value rose 6.7% quarter-over-quarter to $771M.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.